Update on the clinical utility of once-daily tacrolimus in the management of transplantation.

Drug Des Devel Ther · 2015 · PMC4428359 · PMID 26005334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the difference in rejection rate did not reach statistical significance, the authors note a trend toward higher mean tacrolimus levels in the twice-daily tacrolimus group who did not experience BPAR compared to those who developed BPAR.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.